Research has demonstrated that ellagic acid not only ameliorates hyperglycemia in STZ-induced diabetes, lowers blood glucose levels, and attenuates neuroinflammation [12] but also enhances the expression of glucose transporter protein (GLUT4) and PPARγ in skeletal muscle, safeguards pancreatic β-cells against reactive oxygen species, and improves insulin resistance [13]. Here, PPARG is linked to Hyperglycemia.